CLINICAL_TRIALS
trial_result
· 2017-01-31
Clinical Trial Update: Aspirin in Asymmetrically Intrauterine Growth [Phase 2]
Summary
A Phase 2 trial evaluating aspirin for asymmetrical intrauterine growth restriction has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assiut University | Conditions: Intrauterine Growth Restriction Asymmetrical | Phase 2 | Status: COMPLETED